How should treatment effect on spinal radiographic progression in patients with ankylosing spondylitis be measured?
How should treatment effect on spinal radiographic progression in patients with ankylosing spondylitis be measured?
复制标题
DOI:
10.1002/art.21133
复制
发表时间:
2005-07-01
影响因子:
--
通讯作者:
van der Linden, S
中科院分区:
文献类型:
--
作者:
van der Heijde, D;Landewé, R;van der Linden, S
Ankylosing spondylitis (AS) is a chronic inflammatory disease characterized by pain, stiffness, and often, impaired mobility of the spine. The latter is due to spinal inflammation as well as the formation of erosions and vertebral syndesmophytes, and may result in complete ankylosis (“bamboo spine”). AS has a burden of illness comparable with that of rheumatoid arthritis (RA)(1–3). Recent research from our group has now convincingly shown that radiographic damage in AS interferes with long-term functioning, independent of actual disease activity (4), and therefore, radiographic damage is an important target for therapeutic intervention.Previous experience in the field of RA may create the impression that the causal chain of inflammation leading to radiographic damage may hold for AS, as has been proven for RA. However, firm evidence that inflammation of the spine in AS actually precedes radiographic damage in a causal manner is currently lacking. To date, it has also not been possible to predict at an early stage which patients will develop significant radiographic damage of the spine over time and which patients will not. In the Outcome in Ankylosing Spondylitis International Study (OASIS)(5)(see below), the only variable with some prognostic ability regarding